๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Navi Mumbai
Clinical trial register · India

Clinical Trials in Navi Mumbai

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Tata Memorial Centre11 Tata Memorial Hospital6 AstraZeneca2 Newron Pharmaceuticals SPA1 Rousselot BVBA1
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
27 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India
NCT07459543Unresectable Melanoma, Metastatic Melanoma
Bristol-Myers Squibb
Phase 4
40
Nashik, Mumbai, Navi Mumbai, Pune, Bhubaneswar, Chennai, Nagpur, New Delhi
2026-11-15
Recruiting
A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals
NCT07572240Healthy, Stress
Rousselot BVBA
Not applicable
72
Nashik, Navi Mumbai, Pimpri-Chinchwad, Pune, Thane
2026-07-27
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
NCT07720284High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca
Phase 3
915
Kolkata, Kottayam, Nashik, Navi Mumbai, New Delhi
2026-07-16
Recruiting
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110Metastatic Castration-resistant Prostate Cancer
AstraZeneca
Phase 3
670
Bangalore, Gurgaon, Navi Mumbai
2026-05-04
Recruiting
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
NCT07404176Neuroendocrine Neoplasms (Tumours), Neuroendocrine Tumors, Metastatic Neuroendocrine Tumors
Tata Memorial Hospital
Phase 2
20
Mumbai, Navi Mumbai
2026-03-01
Recruiting
Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
NCT07226089ISS, SGA
Rabin Medical Center
Phase 3
254
Maheshra, Navi Mumbai, New Delhi
2026-02-01
Recruiting
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
NCT07184619Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA
Phase 3
400
Vijayawada, Guwahati, Mumbai, Nagpur, Navi Mumbai, Madurai, Bฤซbฤซnagar, Lucknow
2026-01-23
Recruiting
Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NCT05774483Mouth Neoplasms, Oral Cancers, Oral Squamous Cell Carcinoma (OSCC), Oral Squamous Cell Carcinomas
Tata Memorial Hospital
Not applicable
508
Mumbai, Navi Mumbai, Varanasi
2025-04-16
Recruiting
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
NCT07719946Haploidentical Hematopoietic Stem Cell Transplant, Hematological Malignancies
Tata Memorial Centre
Phase 2
20
Navi Mumbai
2025-03-26
Recruiting
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
NCT07724873Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease, Hematological Malignancy
Tata Memorial Centre
Phase 1/2
54
Navi Mumbai
2025-01-28
Active, closed
Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry
NCT07354087Endometrial Cancer
Tata Memorial Hospital
Observational
300
Mumbai, Navi Mumbai
2024-11-28
Recruiting
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
NCT07709195Oral Mucositis, Total Body Irradiation, Hematological Malignancies, Hematopoietic Stem Cell Transplantation (HSCT)
Tata Memorial Centre
Phase 2
17
Navi Mumbai
2024-10-30
Recruiting
Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
NCT07709013Hematologic Malignancies
Tata Memorial Centre
Phase 2
22
Navi Mumbai
2024-10-18
Recruiting
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
NCT06644846Cervical Cancer, Gynecologic Cancer, Recurrent Cancer
Tata Memorial Hospital
Not applicable
20
Navi Mumbai
2024-10-04
Recruiting
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
NCT06831370Hodgkin Lymphoma
Takeda
Phase 4
124
Vijayawada, Guwahati, Surat, Bangalore, Puducherry, Nashik, Navi Mumbai, Pune
2024-08-28
Recruiting
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia
NCT06058572Acute Leukemia
Tata Memorial Centre
Phase 2
166
Navi Mumbai
2024-08-02
Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
NCT06104566CLL/SLL
Ascentage Pharma Group Inc.
Phase 3
400
Gandhinagar, Gurugramam, Jhajjar, Bangalore, Mysuru, Navi Mumbai, Pune, Delhi
2023-12-20
Recruiting
Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.
NCT07708987Hematological Malignancy, GVHD - Graft-Versus-Host Disease, Steriod Refractory
Tata Memorial Centre
Phase 2
34
Navi Mumbai
2023-09-23
Recruiting
Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"
NCT07021677T Acute Lymphoblastic Leukemia
Tata Memorial Centre
Phase 2
18
Navi Mumbai
2023-08-28
Recruiting
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
NCT05857631Cervical Cancer, Endometrial Cancer
Tata Memorial Centre
Not applicable
90
Navi Mumbai, Mumbai
2023-05-29
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Recruiting
Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer
NCT05102240Cervix Cancer
Tata Memorial Hospital
Observational
1,800
Navi Mumbai
2022-02-24
Recruiting
Radiotherapy vs Observation for Post Chemotherapy Residual Mass in Advanced Seminoma
NCT05142982Seminoma
Tata Memorial Centre
Not applicable
74
Mumbai, Navi Mumbai
2021-12-01
Recruiting
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
NCT04809324Oral Cavity Cancer
Dr.Pankaj Chaturvedi
Not applicable
1,206
Mumbai, Navi Mumbai, Varanasi
2021-11-15
Recruiting
PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)
NCT07185672Neuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3, Neuroendocrine Gastroenteropancreatic Tumour
Tata Memorial Hospital
Phase 3
162
Mumbai, Navi Mumbai
2019-08-07
Rows per page Showing 1–25 of 27
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/navi-mumbai

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.